Ocugen stock drops after FDA places clinical hold on study of COVID-19 vaccine candidate Covaxin
Shares of Ocugen Inc. sank 6.9% premarket, after the biotechnology company said the U.S. Food and Drug Administration placed a "clinical hold" on the Phase...